Increasing demand to curb drug toxicity at the drug development phase coupled with new drug development is expected to fuel growth of ADME toxicology testing market over the forecast period. ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage failure of drugs in human body, as the results observed in animal models and human are different. To overcome this drug failure hurdle drug manufacturers are incorporating ADME toxicity testing in early drug developmental phases. Increasing adoption of ADME toxicity testing as cost and time curbing tool is further expected to drive growth of this market. Introduction of technologically advanced computer based testing models are additionally fuelling growth of this market.
ADME toxicity testing market is studied with respect to in-vitro and in-vivo technologies. In-vitro technologies are expected to register lucrative growth owing to increasing ethical concerns over animal use in clinical trials. Insilico technologies of in-vivo testing are gaining popularity due to its capability of effective cost reduction due to early ADME toxicology prediction. Use of ADME toxicity computer modeling is expected to rise because of associated benefits related to increase throughput screening.
Geographically, North America is expected to have the largest market share in terms of revenue followed by Europe during the forecast period. Larger base of drug manufacturing organizations coupled with supportive government regulations pertaining to drug development are key drivers for the growth of this regional market. Additionally, increasing R&D investments related to drug discovery is also expected to propel growth of this market. Asia Pacific is expected to have a lucrative growth owing to rapidly improving healthcare infrastructure, rising spending in healthcare & diagnostic centers, increasing patient awareness levels and increased access to healthcare services in the emerging economies of India and China.
Major players of the market are Bio-Rad Laboratories, Inc., Accelrys, Inc., Agilent Technologies, Inc., Caliper Life Sciences, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation,Thermo Fisher Scientific, Inc. Molecular Discovery Ltd., and Optivia Biotechnology, Inc
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.